When considering what names to put on your watch list, focus on stocks with an 80 or higher RS Rating. Masimo now meets that criteria, with a jump from 76 to 82 Monday.
Risk Management In The Stock Market: How Much Money To Invest Now
This exclusive rating from Investor's Business Daily tracks share price action with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the last 52 weeks holds up against all the other stocks in our database.
Decades of market research shows that the best stocks typically have an RS Rating north of 80 in the early stages of their moves.
Masimo is working on a consolidation with a 194.88 buy point. See if it can break out in heavy trade.
In terms of revenue and profits, Masimo has posted four quarters of increasing earnings growth. Revenue growth has also moved higher over the same time frame.
Masimo earns the No. 2 rank among its peers in the Medical-Systems/Equipment industry group. iRadimed is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
